EUVIMEDEUVIMED entdecken
Crossref

Differential gene set enrichment of the epithelial–mesenchymal transition pathway in BRAF- vs. NRAS -mutated metastatic melanoma

Victor J Raimundi-Santos, Tyrel R Porter iD

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Victor J Raimundi-Santos und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Melanoma, Proto-Oncogene Proteins B-raf, GTP Phosphohydrolases. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a leading cause of cancer-related deaths and is frequently driven by mutations in the BRAF and NRAS genes. These mutations disrupt key cellular signalling pathways that promote tumour growth and metastasis, but they have distinct biological and clinical implications, particularly in their response to treatment and impact on patient prognosis. The epithelial–mesenchymal transition (EMT) is a process in which epithelial cells undergo changes in response to specific transcription factors. There are currently few studies investigating the EMT within BRAF and NRAS mutations. The aim of this study was to further elucidate activation of the EMT pathway in metastatic melanoma, focusing on BRAF- and NRAS-mutated samples from The Cancer Genome Atlas. Gene Set Enrichment Analysis revealed that BRAF mutations were more significantly associated with increased EMT activation relative to all other mutations in the dataset. In contrast, NRAS mutations were not significantly associated with gene expression of the EMT pathway, suggesting alternative mechanisms for metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionMelanomaProto-Oncogene Proteins B-rafGTP PhosphohydrolasesMembrane ProteinsSkin NeoplasmsHumansMutationSignal Transduction

Substanzen

Proto-Oncogene Proteins B-rafNRAS protein, humanGTP PhosphohydrolasesBRAF protein, humanMembrane Proteins

Autor:innen und Institutionen

  • School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
  • School of Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico.

ORCID-Profile: Tyrel R Porter

Zitieren

APA

Raimundi-Santos, V. J., & Porter, T. R. (2025). Differential gene set enrichment of the epithelial–mesenchymal transition pathway in BRAF- vs. NRAS -mutated metastatic melanoma. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf023

Vancouver

Raimundi-Santos VJ, Porter TR. Differential gene set enrichment of the epithelial–mesenchymal transition pathway in BRAF- vs. NRAS -mutated metastatic melanoma. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf023

BibTeX
@article{RaimundiSantos2025,
  author = {Raimundi-Santos, Victor J and Porter, Tyrel R},
  title = {Differential gene set enrichment of the epithelial–mesenchymal transition pathway in BRAF- vs. NRAS -mutated metastatic melanoma},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf023}
}
Kostenlos starten →